![Marc Zabeau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Zabeau
Fondatore presso QBIC Venture Partners BV
Posizioni attive di Marc Zabeau
Società | Posizione | Inizio | Fine |
---|---|---|---|
QBIC Venture Partners BV
![]() QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Fondatore | 23/05/2012 | - |
Investitore di Private Equity | 23/05/2012 | - | |
Biogazelle NV
![]() Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium. | Direttore/Membro del Consiglio | - | - |
THERAtRAME SA
![]() THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Presidente | - | - |
Independent Dir/Board Member | - | - |
Storia della carriera di Marc Zabeau
Precedenti posizioni note di Marc Zabeau
Società | Posizione | Inizio | Fine |
---|---|---|---|
UGent TechTransfer
![]() UGent TechTransfer Investment ManagersFinance UGent TechTransfer is a venture capital firm, a subsidiary of Ghent University founded in 1999. UGent TechTransfer is headquartered in Zwijnaarde, Belgium. | Investitore di Private Equity | 23/09/2009 | 30/11/2011 |
Presidente | 23/09/2009 | 30/11/2011 | |
Confo Therapeutics NV
![]() Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Direttore/Membro del Consiglio | - | - |
Trinean NV
![]() Trinean NV Electronic Equipment/InstrumentsElectronic Technology Trinean NV develops and produces nanoliter spectrophotometers and consumables. Its products include DropSense96, Xpose, and spectral content profiling. The firm covers both microfluidic structures and multi-channel spectrometry for microliter sample handling. The company was founded by Ronny Baeckstaele and Kris Naessens in 2006 and is headquartered in Gentbrugge, Belgium. | Direttore/Membro del Consiglio | - | - |
Formazione di Marc Zabeau
Ghent University | Doctorate Degree |
Statistiche
Distribuzione geografica
Belgio | 8 |
Posizioni
Director/Board Member | 3 |
Private Equity Investor | 2 |
President | 1 |
Settori
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
UGent TechTransfer
![]() UGent TechTransfer Investment ManagersFinance UGent TechTransfer is a venture capital firm, a subsidiary of Ghent University founded in 1999. UGent TechTransfer is headquartered in Zwijnaarde, Belgium. | Finance |
Trinean NV
![]() Trinean NV Electronic Equipment/InstrumentsElectronic Technology Trinean NV develops and produces nanoliter spectrophotometers and consumables. Its products include DropSense96, Xpose, and spectral content profiling. The firm covers both microfluidic structures and multi-channel spectrometry for microliter sample handling. The company was founded by Ronny Baeckstaele and Kris Naessens in 2006 and is headquartered in Gentbrugge, Belgium. | Electronic Technology |
QBIC Venture Partners BV
![]() QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Finance |
Biogazelle NV
![]() Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
Confo Therapeutics NV
![]() Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Health Technology |
THERAtRAME SA
![]() THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Health Technology |
- Borsa valori
- Insiders
- Marc Zabeau
- Esperienza